Beerens N, Heutink R, Bergervoet SA, Harders F, Bo. Multiple Reassorted Viruses as Cause of Highly Pathogenic Avian Influenza A(H5N8) Virus Epidemic, the Netherlands, 2016. Emerg Infect Dis. 2017 Dec. Abstract
submitted by kickingbird at Nov, 4, 2017 from Emerg Infect Dis. 2017 Dec (via https://wwwnc.cdc.gov/eid/article/23/12/17-1062_article)
In 2016, an epidemic of highly pathogenic avian influenza A virus subtype H5N8 in the Netherlands caused mass deaths among wild birds, and several commercial poultry farms and captive bird holdings were ... Kleyheeg E, Slaterus R, Bodewes R, Rijks JM, Spier. Deaths among Wild Birds during Highly Pathogenic Avian Influenza A(H5N8) Virus Outbreak, the Netherlands. Emerg Infect Dis. 2017 Dec. Abstract
submitted by kickingbird at Nov, 4, 2017 from Emerg Infect Dis. 2017 Dec (via https://wwwnc.cdc.gov/eid/article/23/12/17-1086_article)
During autumn–winter 2016–2017, highly pathogenic avian influenza A(H5N8) viruses caused mass die-offs among wild birds in the Netherlands. Among the ≈13,600 birds reported dead, most were tufted ducks ... Xiangjun Du, etc.,al. Evolution-informed forecasting of seasonal influenza A (H3N2). Science Translational Medicine 25 Oct 2017. Abstract
submitted by kickingbird at Nov, 1, 2017 from Science Translational Medicine 25 Oct 2017 (via http://stm.sciencemag.org/content/scitransmed/9/413/eaan5325)
Interpandemic or seasonal influenza A, currently subtypes H3N2 and H1N1, exacts an enormous annual burden both in terms of human health and economic impact. Incidence prediction ahead of season remains ... Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines. Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine 2017 Oct 10. Abstract
submitted by kickingbird at Nov, 1, 2017 from Vaccine 2017 Oct 10 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29029940/)
Globally the most commonly utilised immunisation against influenza is the trivalent inactivated influenza vaccine (TIV) derived from an A/H1N1, an A/H3N2 and aB type influenza virus. Vaccine effectiveness ... Ortiz JR, Hombach J. Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines. Vaccine 2017 Oct 14. Abstract
submitted by kickingbird at Nov, 1, 2017 from Vaccine 2017 Oct 14 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29042200/)
In 2017, the World Health Organization (WHO) published a document aimed at facilitating influenza vaccine introduction and use in low- and middle-income countries. The document "The Immunological Basis ... Buffin S, Ikhelef N, Prudent J, Dubayle J, et al. A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines. J Virol Methods 2017. Abstract
submitted by kickingbird at Nov, 1, 2017 from J Virol Methods 2017 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29030070/)
To formulate inactivated influenza vaccines, the concentration of hemagglutinin (HA) must be accurately determined. The standard test currently used to measure HA in influenza vaccines is the Single Radial ... Jianzhong Shi,etc.,al. H7N9 virulent mutants detected in chickens in China pose an increased threat to humans. Cell Research 24 Oct, 2017. Abstract
submitted by kickingbird at Oct, 31, 2017 from Cell Research 24 Oct, 2017 (via https://www.nature.com/cr/journal/vaop/ncurrent/full/cr20171)
Certain low pathogenic avian influenza viruses can mutate to highly pathogenic viruses when they circulate in domestic poultry, at which point they can cause devastating poultry diseases and severe economic ... M Imai,etc.,al. A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets. Cell Host & Microbe. Abstract
submitted by kickingbird at Oct, 23, 2017 from Cell Host & Microbe (via http://www.cell.com/cell-host-microbe/fulltext/S1931-3128%28)
Highly pathogenic avian influenza (HPAI) H7N9 viruses replicate efficiently in mammals HPAI H7N9 viruses are more pathogenic than low pathogenic H7N9 viruses in mammals HPAI H7N9 viruses transmit ... Bradley JS, Blumer JL, Romero JR, Michaels MG, et. Intravenous Zanamivir in Hospitalized Patients With Influenza. Pediatrics 2017 Oct 19.. Abstract
submitted by kickingbird at Oct, 22, 2017 from Pediatrics 2017 Oct 19. (via https://www.ncbi.nlm.nih.gov/m/pubmed/29051331/)
BACKGROUND: Children with severe influenza infection may require parenteral therapy if oral or inhaled therapies are ineffective or cannot be administered. Results from a study investigating intravenous ... Lion A, Richard M, Esnault E, Kut E, et al. Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.. Virology 2017;513:29-42. Abstract
submitted by kickingbird at Oct, 22, 2017 from Virology 2017;513:29-42 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29031164/)
Endotheliotropism is a hallmark of gallinaceous poultry infections with highly pathogenic avian influenza (HPAI) viruses and a feature that distinguishes HPAI from low pathogenic avian influenza (LPAI) ... Frabutt DA, Wang B, Riaz S, Schwartz RC, et al. Innate sensing of influenza A virus hemagglutinin glycoproteins by the host endoplasmic reticulum (ER) stress pathway triggers a potent antiviral response via ER-associated protein degradation. J Virol 2017 Oct 18.. Abstract
submitted by kickingbird at Oct, 22, 2017 from J Virol 2017 Oct 18. (via https://www.ncbi.nlm.nih.gov/m/pubmed/29046440/)
Innate immunity provides an immediate defense against infection after host cells sense "danger" signals from microbes. Endoplasmic reticulum (ER) stress arises from accumulation of misfolded/unfolded proteins ... Sutton TC, Lamirande EW, Bock KW, Moore IN, et al. In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice. J Virol 2017 Oct 18. Abstract
submitted by kickingbird at Oct, 22, 2017 from J Virol 2017 Oct 18 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29046448/)
Influenza viruses of the H1N1, H2N2, and H3N2 subtypes have caused previous pandemics. H2 influenza viruses represent a pandemic threat due to continued circulation in wild birds and limited immunity in ... Liu H, Grantham ML, Pekosz A. Mutations in the Influenza A virus M1 protein enhance virus budding to complement lethal mutations in the M2 cytoplasmic tail. J Virol 2017 Oct 18. Abstract
submitted by kickingbird at Oct, 22, 2017 from J Virol 2017 Oct 18 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29046451/)
The influenza A virus M1 and M2 proteins play important roles in virus assembly and in the morphology of virus particles. Mutations in the distal cytoplasmic tail region of M2, and in particular a tyrosine ... Choi WS, Jeong JH, Kwon JJ, Ahn SJ, et al. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6 and N8 Neuraminidase Subtypes. J Virol 2017 Oct 18.. Abstract
submitted by kickingbird at Oct, 22, 2017 from J Virol 2017 Oct 18. (via https://www.ncbi.nlm.nih.gov/m/pubmed/29046464/)
Several subtypes of avian influenza viruses (AIVs) are emerging as novel human pathogens, and the frequency of related infections has increased in recent years. Although neuraminidase (NA) inhibitors (NAIs) ... Skowronski DM, Chambers C, Sabaiduc S, De Serres G. Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada. J Infect Dis 2017 Oct 4. Abstract
submitted by kickingbird at Oct, 22, 2017 from J Infect Dis 2017 Oct 4 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29029166/)
Background: Vaccine effectiveness (VE) estimates are reported from Canada's Sentinel Practitioner Surveillance Network (SPSN) for the 2015-16 influenza season, characterized by a delayed A(H1N1)pdm09 ... Gordon NA, McGuire KL, Wallentine SK, Mohl GA, et. Divalent copper complexes as influenza A M2 inhibitors. Antiviral Res 2017;147:100-106. Abstract
submitted by kickingbird at Oct, 22, 2017 from Antiviral Res 2017;147:100-106 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29032206/)
New M2 blockers effective against the ubiquitous amantadine-resistant S31N M2 mutation in influenza A are needed. Six copper complexes, 2, 4, 6, 8, 9, and 10, were synthesized and found to block both wild ... Duh D, Blazic B. Single mutation in the matrix gene of seasonal influenza A viruses critically affects the performance of diagnostic molecular assay. J Virol Methods 2017 Oct 6. Abstract
submitted by kickingbird at Oct, 15, 2017 from J Virol Methods 2017 Oct 6 (via https://www.ncbi.nlm.nih.gov/m/pubmed/28993123/)
Reduced intensity of the fluorescence signal in the amplification curve was observed when using a WHO recommended real time RT-PCR for influenza virus detection. A single mutation, G189T, in the conserved ... Cho J, Yi H, Jang EY, Lee MS, et al. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection. Biochem Biophys Res Commun 2017 Oct 7. Abstract
submitted by kickingbird at Oct, 15, 2017 from Biochem Biophys Res Commun 2017 Oct 7 (via https://www.ncbi.nlm.nih.gov/m/pubmed/29017920/)
Infection with the highly pathogenic avian influenza H5N1 virus results in a high incidence of mortality in humans. Severe complications from infection are often associated with hypercytokinemia. However, ... Tilmanis D, van Baalen C, Oh DY, Rossignol JF, et. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide. Antiviral Res 2017 Oct 3. Abstract
submitted by kickingbird at Oct, 15, 2017 from Antiviral Res 2017 Oct 3 (via https://www.ncbi.nlm.nih.gov/m/pubmed/28986103/)
Nitazoxanide is a thiazolide compound that was originally developed as an anti-parasitic agent, but has recently been repurposed for the treatment of influenza virus infections. Thought to exert its anti-influenza ... Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM,. COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants. J Virol 2017 Oct 4. Abstract
submitted by kickingbird at Oct, 9, 2017 from J Virol 2017 Oct 4 (via https://www.ncbi.nlm.nih.gov/m/pubmed/28978710/)
Each influenza season, a set of wild-type viruses, representing one H1N1, one H3N2, 1-2 influenza B isolates, are selected for inclusion in the annual seasonal influenza vaccine. In order to develop broadly ... 8178 items, 20/Page, Page[258/409][|<<] [|<] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [>|] [>>|] |
Related Pages:
Browse by Category
Learn about the flu news, articles, events and more
Subscribe to the weekly F.I.C newsletter!
|
- 
